Skip to main content
OpenTrials
Completed

NCT Number: NCT02915653

Adult Primary and Preventive Practice (APPP) Study

The study is a pre-post two round, randomized controlled study design of PCPs randomly assigned to a control or 1 of 2 intervention arms.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

QURE Healthcare

San Francisco, California, 94109, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 1. Provide consent to participate in the study 2. Board-certified physician currently practicing in the following areas: 3. Internal medicine 4. Family medicine 5. Have practiced as a board-certified physician in internal or family medicine for greater than 2 but less than 30 years. 6. English-speaking 7. Community / non-academic based practice setting 8. ≥ 40 patients under care weekly 9. Access to the internet

Exclusion criteria

  • 1. Not board certified in their respective area of care 2. Academic-based practice 3. Have practiced as a board-certified physician for less than 2 or greater than 30 years 4. Follow <40 patients weekly 5. Non-English speaking 6. Unable to access the internet

Treatment and study plan

Educational materials on a new diagnostic service

Other

Educational materials on a new diagnostic service

Primary outcomes

  1. Quality of Care

    Time frame: 8 weeks

    Difference in difference of combined diagnostic and treatment CPV domain scores, including colonoscopy referral rates, in post-intervention versus baseline comparing intervention and control groups among the three patient types.

Secondary outcomes

  1. Intervention Impact on Care

    Time frame: 8 weeks

    Difference in difference between the control and intervention groups in the overall quality of care for CRC screening and for adult primary prevention care measured by the combined and individual item CPV scores for the three patient types.

  2. Healthcare Utilization

    Time frame: 8 weeks

    Difference in health care utilization and/or costs in patients tested with SimpliPro Colon™ versus the control group.

  3. Diagnostic Method Comparison

    Time frame: 8 weeks

    Difference in recommendation of CRC evaluation with colonoscopy and/or flexible sigmoidoscopy, double barium enema, or CT colonography, including risk-level and urgency pre- and post-intervention, between intervention and control groups

Sponsors and collaborators

Lead sponsor

Qure Healthcare, LLC

Industry

Collaborators

  • Applied Proteomics Inc

Registry information

Acronym: APPP

Important dates

Study start
2016
Primary completion
2016
Study completion
2017
First posted
Sep 27, 2016
Registry last updated
Jun 20, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.